Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP655859.RAYFNQPqsknranwCIbdKe9mQmguG_N8BBDV2lvXR46OJA130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP655859.RAYFNQPqsknranwCIbdKe9mQmguG_N8BBDV2lvXR46OJA130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP655859.RAYFNQPqsknranwCIbdKe9mQmguG_N8BBDV2lvXR46OJA130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP655859.RAYFNQPqsknranwCIbdKe9mQmguG_N8BBDV2lvXR46OJA130_provenance.
- NP655859.RAYFNQPqsknranwCIbdKe9mQmguG_N8BBDV2lvXR46OJA130_assertion description "[We describe a 65-year old woman who developed a t(8;16)(p11;p13) positive acute myeloid leukemia (AML)-M4 without a prior myelodysplasia thirty-six months after a low-grade non-Hodgkin's lymphoma treated with alkylating agents (chlorambucil and cyclophosphamide) and fludarabine, a purine analog with a significant activity in lymphoproliferative disorders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP655859.RAYFNQPqsknranwCIbdKe9mQmguG_N8BBDV2lvXR46OJA130_provenance.
- NP655859.RAYFNQPqsknranwCIbdKe9mQmguG_N8BBDV2lvXR46OJA130_assertion evidence source_evidence_literature NP655859.RAYFNQPqsknranwCIbdKe9mQmguG_N8BBDV2lvXR46OJA130_provenance.
- NP655859.RAYFNQPqsknranwCIbdKe9mQmguG_N8BBDV2lvXR46OJA130_assertion SIO_000772 11025602 NP655859.RAYFNQPqsknranwCIbdKe9mQmguG_N8BBDV2lvXR46OJA130_provenance.
- NP655859.RAYFNQPqsknranwCIbdKe9mQmguG_N8BBDV2lvXR46OJA130_assertion wasDerivedFrom befree-20140225 NP655859.RAYFNQPqsknranwCIbdKe9mQmguG_N8BBDV2lvXR46OJA130_provenance.
- NP655859.RAYFNQPqsknranwCIbdKe9mQmguG_N8BBDV2lvXR46OJA130_assertion wasGeneratedBy ECO_0000203 NP655859.RAYFNQPqsknranwCIbdKe9mQmguG_N8BBDV2lvXR46OJA130_provenance.
- befree-20140225 importedOn "2014-02-25" NP655859.RAYFNQPqsknranwCIbdKe9mQmguG_N8BBDV2lvXR46OJA130_provenance.